Variant report
Variant | nsv604537 |
---|---|
Chromosome Location | chr6:114224070-114224975 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr6:114224954-114225056 | GM12878 | blood: | n/a | n/a |
2 | REST | chr6:114224852-114225121 | K562 | blood: | n/a | chr6:114224979-114224992 chr6:114224983-114224992 |
3 | REST | chr6:114224790-114225474 | PFSK-1 | brain: | n/a | chr6:114224979-114224992 chr6:114224983-114224992 |
4 | REST | chr6:114224907-114225127 | SK-N-SH | brain: | n/a | chr6:114224979-114224992 chr6:114224983-114224992 |
5 | REST | chr6:114224710-114225535 | PFSK-1 | brain: | n/a | chr6:114224979-114224992 chr6:114224983-114224992 |
6 | SIN3AK20 | chr6:114224922-114225393 | PFSK-1 | brain: | n/a | n/a |
7 | TAF1 | chr6:114224940-114225435 | PFSK-1 | brain: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:114218743..114220678-chr6:114223116..114225137,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000175967 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188434499 | chr6:114224118-114224119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564775665 | chr6:114224121-114224122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551049693 | chr6:114224135-114224136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201190752 | chr6:114224232-114224233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113927728 | chr6:114224234-114224235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559851698 | chr6:114224235-114224236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560092436 | chr6:114224239-114224240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527529760 | chr6:114224254-114224255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs397822658 | chr6:114224256-114224257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574237300 | chr6:114224282-114224283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191341272 | chr6:114224295-114224296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532633215 | chr6:114224337-114224338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534994625 | chr6:114224383-114224384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567916401 | chr6:114224400-114224401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs377708661 | chr6:114224488-114224489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs118159370 | chr6:114224543-114224544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73551249 | chr6:114224544-114224545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371774158 | chr6:114224596-114224597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs151014687 | chr6:114224604-114224605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6917232 | chr6:114224631-114224632 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs566199539 | chr6:114224647-114224648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571928554 | chr6:114224767-114224768 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs183726421 | chr6:114224778-114224779 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs554675576 | chr6:114224794-114224795 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs573829529 | chr6:114224820-114224821 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs578251619 | chr6:114224910-114224911 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs140869163 | chr6:114224916-114224917 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs59295167 | chr6:114224922-114224923 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs539340709 | chr6:114224937-114224938 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs189162821 | chr6:114224968-114224969 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Cancer | 17160897 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Acute lymphoblastic leukemia | 17229543 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:114223000-114225200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr6:114223000-114225200 | Weak transcription | HUVEC | blood vessel |
3 | chr6:114223200-114225600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr6:114223400-114225000 | Weak transcription | NHDF-Ad | bronchial |
5 | chr6:114223400-114225200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
6 | chr6:114223400-114225200 | Weak transcription | Osteobl | bone |
7 | chr6:114223600-114225000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr6:114223600-114225000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
9 | chr6:114223600-114225200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr6:114223600-114225200 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
11 | chr6:114223800-114225000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
12 | chr6:114223800-114225200 | Weak transcription | Colon Smooth Muscle | Colon |
13 | chr6:114223800-114225200 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
14 | chr6:114224000-114225000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr6:114224000-114225000 | Weak transcription | Fetal Muscle Leg | muscle |
16 | chr6:114224000-114225000 | Weak transcription | HepG2 | liver |
17 | chr6:114224400-114225000 | Weak transcription | Fetal Muscle Trunk | muscle |
18 | chr6:114224600-114226200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
19 | chr6:114224800-114225000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
20 | chr6:114224800-114225000 | Enhancers | Stomach Smooth Muscle | stomach |
21 | chr6:114224800-114226000 | Enhancers | Rectal Smooth Muscle | rectum |
22 | chr6:114224800-114226600 | Enhancers | Fetal Stomach | stomach |